You are here: Industry Insights > CKD

News List

Astellas’ kidney disease drug shows promise in PhIII pharmatimes
September 27, 2018
A Phase III study assessing Astellas’ roxadustat in patients with chronic kidney disease (CKD) and anaemia who are not receiving dialysis has met its key endpoints.
Keryx’s Auryxia shows potential in delaying dialysis in kidney patients biospectrumasia
May 29, 2018
Results from an open-label investigator-sponsored study assessing Keryx Biopharmaceuticals' Auryxia (ferric citrate) in patients with advanced chronic kidney disease (CKD) showed its potential for delaying the need for dialysis.
UK study to investigate kidney disease progression pharmatimes
April 16, 2018
A large-scale observational study of chronic kidney disease (CKD) is due to launch in general practices this month, involving 3,205 Oxfordshire residents and led by Oxford University researchers.
Chronic kidney disease player Osprey Medical nabs $17M+ fiercebiotech
August 10, 2017
The DyeVert Plus system tracks how much contrast dye is used for each image and tells physicians when they have met a preset threshold.
Zydus starts phase II trial of ZYAN1 for treating anaemia in patients with CKD financialexpress
July 06, 2017
ZYAN1 has been shown to improve iron mobilisation and has the potential to reduce or eliminate the need for iron supplementation
Zydus starts phase II trial of ZYAN1 for treating anaemia in patients with CKD expressbpd
July 06, 2017
ZYAN1 has been shown to improve iron mobilisation and has the potential to reduce or eliminate the need for iron supplementation

Previous page 1 2 3 4 5 6 Next page